No Picture
Trading Ideas

Aveo’s Tivozanib Gets FDA Nod For New Drug Application To Treat Kidney Cancer

Aveo Oncology (AVEO) announced that the U.S. Food and Drug Administration approved the New Drug Application (NDA) for its tivozanib used for the treatment of kidney cancer.Tivozanib is the company’s next-generation vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) targeted for the treatment of relapsed or refractory renal cell carcinoma (RCC). The FDA has assigned the application standard review and a Prescription Drug User Fee Act target deadline date of March 31, 2021.“The acceptance of our NDA filing marks yet another important milestone for AVEO, as we pursue our goal of providing RCC patients whose disease has relapsed or …read more […]

No Picture
Trading Ideas

Lufthansa Gains Following Breakthrough on $10 Billion Bailout

(Bloomberg) — Deutsche Lufthansa AG shares surged after Europe’s biggest airline overcame most of the barriers to receiving a 9 billion-euro ($10 billion) bailout from the German government.The stock gained as much as 8.3% and was priced 6.6% higher at 9.75 euros as of 9:04 a.m. Tuesday, the first day of trading on the Frankfurt bourse since last week.Barriers to the rescue began to crumble late Friday, with Lufthansa agreeing to hand over operating slots at its main hubs to win European Union backing for the deal. Its supervisory board approved the compromise in a vote on Monday.Lufthansa is seeking …read more […]

No Picture
Trading Ideas

TietoEVRY, IBM drop arbitration cases, revamp co-operation deal

“Following this new agreement TietoEVRY and IBM have no notices of arbitration,” it said in the statement. Last year both companies submitted notices of arbitration related to their co-operation. As part of the deal some 180 employees currently employed by IBM will join TietoEVRY’s cloud specialists team, and some 25 employees currently employed by TietoEVRY will join IBM. …read more […]

No Picture
Trading Ideas

Visa Sees Solid Uptick In Spending As Lockdown Eases

Visa (V) has indicated a solid uptick in consumer spending from April to May, as it continues to actively monitor the Covid-19 impact globally.Most notably, in May, total U.S. payments volume declined 5% year-over-year, a 13 percentage point (ppt) improvement over April. Meanwhile debit grew 12% and credit declined 21% year-over-year in May, a 17 ppt and 9 ppt improvement over April, respectively.“The continued distribution of Economic Impact Payments and the relaxing of shelter-in-place restrictions in a number of states are driving these trends” Visa stated.However, recovery in international markets in which Visa processes the majority of transactions lagged the …read more […]